Articles from Rosen Law Firm

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Cardlytics, Inc. (NASDAQCDLX) resulting from allegations that Cardlytics may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMedics Group, Inc. (NASDAQTMDX) resulting from allegations that TransMedics may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of stock of BioAge Labs, Inc. (NASDAQBIOA) pursuant and/or traceable to BioAge’s initial public offering conducted on September 26, 2024 (the “IPO”). BioAge describes itself as a “clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Nextracker Inc. (NASDAQNXT) between February 1, 2024 and August 1, 2024. Nextracker describes itself as a company that “provides software that enables solar panels to follow the sun’s movement across the sky and related products and services.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Dave. Inc (NASDAQDAVE) resulting from allegations that Dave may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of Applied Therapeutics, Inc. (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”). Applied Therapeutics is a clinical-stage biopharmaceutical company.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of MGP Ingredients, Inc. (NASDAQMGPI) between May 4, 2023 and October 30, 2024. MGPI describes itself as a company that “engages in the production and supply of distilled spirits, branded spirits, and food ingredients in the United States and internationally.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of Enphase Energy, Inc. (NASDAQENPH) between April 25, 2023 and October 22, 2024. Enphase describes itself as a company that “develops, manufactures, and sells solar microinverters.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of AstraZeneca PLC (NASDAQAZN) resulting from allegations that AstraZeneca may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of securities of The Toronto-Dominion Bank (NYSETD) between February 29, 2024 and October 9, 2024, both dates inclusive (the “Class Period”). TD is an international bank.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Sun Communities, Inc. (NYSESUI) between February 28, 2019 and September 24, 2024. SUI describes itself as a “real estate investment company that focuses its investments on manufactured housing communities, recreational vehicle communities, and marinas.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Edwards Lifesciences Corporation (NYSEEW) between February 6, 2024 and July 24, 2024. Edwards describes itself as an “international company that researches, develops, provides products and technologies for heart valve repair and replacement therapies, as well as critical care monitoring solutions.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Gogoro Inc. (NASDAQSVCO) resulting from allegations that Silvaco may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Marqeta, Inc. (NASDAQMQ) between August 7, 2024 and November 4, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Marqeta investors under the federal securities laws.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers or acquirers of securities, including call options, of Five9, Inc. (NASDAQFIVN) between June 4, 2024 and August 8, 2024. Five9 describes itself as a company that “provides software for a cloud-based contact center.”

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Symbotic Inc. (NASDAQSYM) between February 8, 2024 and November 26, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Symbotic investors under the federal securities laws.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Symbotic Inc. (NASDAQSYM) resulting from allegations that Symbotic may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Quanterix Corporation (NASDAQQTRX) resulting from allegations that Quanterix may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zeta Global Holdings Corp. (NYSEZETA) resulting from allegations that Zeta Global may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of Wolfspeed, Inc. (NYSEWOLF) securities between August 16, 2023 and November 6, 2024, both dates inclusive (the “Class Period”). Wolfspeed is a semiconductor company focused on silicon carbide materials and the fabrication of devices for power applications.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Lilium N.V. (NASDAQLILM) between June 11, 2024 and November 3, 2024. Lilium describes itself as a “start-up aviation company-powered learning automation software company.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of PACS Group, Inc. (NYSEPACS) resulting from allegations that PACS Group may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of Sage Therapeutics, Inc. (NASDAQSAGE) securities between April 12, 2021 and July 23, 2024, both dates inclusive (the “Class Period”). Sage Therapeutics is a biopharmaceutical company that develops and commercializes brain health medicines.

Rosen Law Firm, a leading securities law firm, announces an investigation into Unisys Corporation (NYSEUIS) for potential violations of the federal securities laws.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers and acquirers of securities of Ardelyx, Inc. (NASDAQARDX) between October 31, 2023 and July 1, 2024, both dates inclusive (the “Class Period”). Ardelyx describes itself as a “biotechnology company focused on developing and commercializing therapies for, among other things, patients with chronic kidney disease (“CKD”).”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Stellantis N.V. (NYSESTLA) securities between February 15, 2024 and July 24, 2024, both dates inclusive (the “Class Period”). Stellantis is an automotive company.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Elanco Animal Health Incorporated (NYSEELAN) between November 7, 2023 and June 26, 2024. Elanco describes itself as an “animal health company that develops, manufactures, and markets products for pets and farm animals.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Moderna, Inc. (NASDAQMRNA) between January 18, 2023 and June 25, 2024. Moderna describes itself as a “biotechnology company that discovers, develops, and commercializes messenger RNA (“mRNA”) therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the U.S., Europe, and internationally.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims against OpenSea resulting from allegations that OpenSea may have issued materially misleading information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of AMMO, Inc. (NASDAQPOWW) between August 19, 2020 and September 24, 2024. AMMO describes itself as a “company that designs, produces, and markets ammunition and ammunition component products for public consumers, manufacturers, and law enforcement and military agencies.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of stock of Metagenomi, Inc. (NASDAQMGX) pursuant and/or traceable to the Company’s initial public offering conducted between February 9 and 13, 2024 (the “IPO”). Metagenomi describes itself as a “genetics medicine company.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of WM Technology, Inc. (NASDAQMAPS) resulting from allegations that WM Technology may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Domino’s Pizza, Inc. (NYSEDPZ) between December 7, 2023 and July 17, 2024. Domino’s describes itself as a “global pizza company.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Allarity Therapeutics, Inc. (NASDAQALLR) between May 17, 2022 and July 19, 2024. Allarity describes itself as a “clinical-stage biopharmaceutical company that develops oncology therapeutics.”

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Coinbase Global, Inc. (NASDAQCOIN) between April 14, 2021 and July 25, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Coinbase investors under the federal securities laws.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Lions Gate Entertainment Corp. (NYSE: LGF.A, LGF.B) resulting from allegations that Lions Gate may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) between October 31, 2022 and March 26, 2024. SeaStar describes itself as a “medical technology company developing extracorporeal therapies to reduce the consequences of excessive inflammation on vital organs.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Acadia Healthcare Company, Inc. (NASDAQACHC) resulting from allegations that Acadia Healthcare may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQBOLT) between February 5, 2021 and May 14, 2024. Bolt describes itself as a “clinical-stage biopharmaceutical company, [that] engages in the development of immunotherapies for the treatment of cancer.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of MongoDB, Inc. (NASDAQMDB) between August 31, 2023 and May 30, 2024. MongoDB describes itself as an “American software company that designs, develops, manufactures, and sells developer data platforms and integrated services systems through its document-oriented database program.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Starbucks Corporation (NASDAQSBUX) between November 2, 2023 and April 30, 2024. Starbucks describes itself as an “American multinational chain of coffeehouses and roastery reserves.”

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Super Micro Computer, Inc. (NASDAQSMCI) between August 31, 2023, and August 28, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Super Micro Computer investors under the federal securities laws.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Outset Medical, Inc. (NASDAQOM) between August 1, 2022 and August 7, 2024. Outset Medical describes itself as a “medical technology company.”

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Verve Therapeutics, Inc. (NASDAQVERV) between August 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Verve Therapeutics investors under the federal securities laws.

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Teradata Corporation (NYSETDC) between February 13, 2023 and February 12, 2024, both dates inclusive (the “Class Period”) of the important August 13, 2024 lead plaintiff deadline. Teradata Corporation describes itself as a company that “provides a connected multicloud data platform for enterprise analytics.”

WHY: Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of 2U, Inc. (NASDAQTWOU) between February 9, 2022 and February 12, 2024. 2U, Inc. describes itself as a “an online education platform company which operates through two segments, the Degree Program and the Alternative Credentials segment.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Paragon 28, Inc. (NYSEFNA) resulting from allegations that Paragon 28 may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LegalZoom.com, Inc. (NASDAQLZ) resulting from allegations that LegalZoom may have issued materially misleading business information to the investing public.

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Allarity Therapeutics, Inc. (NASDAQALLR) resulting from allegations that Allarity Therapeutics, Inc. may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of American Airlines Group Inc. (NASDAQAAL) between January 25, 2024 and May 28, 2024. American Airlines describes itself as a “network air carrier, providing scheduled air transportation passenger and cargo services throughout the US and in various other countries around the world.”

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Walgreens Boots Alliance, Inc. (NASDAQWBA) between October 12, 2023 and June 26, 2024. Walgreens describes itself as a “global company that delivers retail and pharmacy, and healthcare services across the United States, Europe, and Latin America.”

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Sprout Social, Inc. (NASDAQSPT) between November 2, 2023 and May 2, 2024. Sprout Social describes itself as a “software company which develops and operates a web-based social media management platform.”

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of MediaAlpha, Inc. (NYSEMAX) resulting from allegations that MediaAlpha, Inc. may have issued materially misleading business information to the investing public.

Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Toyota Motor Corporation (NYSETM) between June 25, 2022 and June 2, 2024, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Toyota investors under the federal securities laws.

Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of all purchasers of securities of Sharecare, Inc. (NASDAQSHCR) between May 10, 2023 and March 28, 2024. Sharecare describes itself as “an interactive health and wellness platform.”

Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSEDOCS) between February 9, 2022 and April 1, 2024. Doximity describes itself as a company that “operates a digital platform that provides connections between, medical information to, and patient scheduling tools for medical professionals.”

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Intel Corporation (NASDAQINTC) between January 25, 2024 and April 25, 2024, both dates inclusive (the “Class Period”), of the important July 2, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQENPH) between February 7, 2023 and April 25, 2023, both dates inclusive (the “Class Period”), of the important July 29, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Li Auto Inc. (NASDAQLI) between February 26, 2024 and May 20, 2024, both dates inclusive (the “Class Period”), of the important July 9, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Hertz Global Holdings, Inc. (NASDAQHTZ) between April 27, 2023 and April 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 30, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSECO) (OTC: CORBF) between June 4, 2019 and May 3, 2022, both dates inclusive (the “Class Period”), of the important June 24, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of The Scotts Miracle-Gro Company (NYSESMG) between November 3, 2021 and August 1, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 5, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rivian Automotive, Inc. (NASDAQRIVN) between August 12, 2022 and February 21, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 30, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of FutureFuel Corp. (NYSEFF) resulting from allegations that FutureFuel may have issued materially misleading business information to the investing public.

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Toyota Motor Corporation (NYSETM) resulting from allegations that Toyota may have issued materially misleading business information to the investing public.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Hertz Global Holdings, Inc. (NASDAQHTZ) between April 27, 2023 and April 24, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 30, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of VinFast Auto Ltd. f/k/a Black Spade Acquisition Co., (NASDAQVFS): (i) pursuant and/or traceable to the prospectus and registration statement (the “Offering Documents”) issued in connection with the Company’s August 14, 2023 merger (“Merger”); and/or (ii) between August 15, 2023 and April 17, 2024, both dates inclusive (the “Class Period”), of the important June 11, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQENPH) between February 7, 2023 and April 25, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 29, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSEDOCS) between February 9, 2022 and April 1, 2024, both dates inclusive (the “Class Period”), of the important June 17, 2024 lead plaintiff deadline.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of AXT, Inc. (NASDAQAXTI) between March 24, 2021 and April 3, 2024, both dates inclusive (the “Class Period”), of the important July 5, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Equinix, Inc. (NASDAQEQIX) between May 3, 2019 and March 24, 2024, both dates inclusive (the “Class Period”), of the important July 1, 2024 lead plaintiff deadline in the securities class action first filed by the Firm.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of UnitedHealth Group Inc. (NYSEUNH) between March 14, 2022 and February 27, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 15, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Inari Medical, Inc. (NASDAQNARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2024.

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Block, Inc. (NYSESQ) resulting from allegations that Block may have issued materially misleading business information to the investing public.

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of those who purchased Digital Asset Securities (including, but not limited to, ALGO, MANA, MATIC, NEAR, SOL, UNI, XLM, and XTZ, as well as Coinbase Earn Accounts) between January 1, 2017 and May 3, 2024, inclusive (the “Class Period”), against Coinbase Global, Inc., Coinbase, Inc., Coinbase Asset Management, and Brian Armstrong (together, “Defendants”). A class action lawsuit has already been filed.